Komori
Mitsui DM Sugar (2109) · FactWorsened

Deterioration in Performance at Thai Affiliate and Decline in Equity-Method Investment Income

First written in FY2017-Q2. 14 of 31 entries say "Worsened", first in FY2019-Q2. Latest entry: FY2026.

31entries
11years
1from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorse2016: 12017: 320172018: 320182019: 420192020: 320202021: 320212022: 420222023: 320232024: 320242025: 220252026: 22026
Same theme, other companies
Recognition of Equity-Method Investment LossesA theme 87 companies write about · 87 as a headwind · 0 as a tailwind

Mitsui DM Sugar moved to the "Worse" side of this theme in 2019, 3 years before the typical company in this theme (2022).

The whole theme swung hardest in 2023: 19 of 68 companies on the "Worse" side.

12 other companies' latest entry also says "Worsened".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 87 companies compared. The sentences above are computed from all 87.
Full recordFilings, disclosures and news, newest first
  1. FY2026WorsenedAnnual report

    「Due mainly to lower royalty income and the recognition of an equity-method investment loss resulting primarily from deteriorating earnings at overseas associates, ordinary profit was ¥12,640 million, down 12.7% from the previous consolidated fiscal year.」

    Equity-method investment gains and losses turned from a ¥240 million gain in the previous fiscal year to a ¥74 million loss in the current fiscal year. Deteriorating earnings at overseas associates weighed on ordinary profit.
  2. 2026-05-15WorsenedRevision of earnings forecasts

    「In non-operating income and expenses, royalty income under licenses for the development and sales rights to fingolimod “FTY720” declined, while the Company recorded equity-method investment losses, mainly due to deteriorating results at overseas affiliates. As a result, ordinary income was ¥12,640 million, down 12.7% year on year.」

    The Company moved from recording equity-method investment gains in the previous fiscal year to recording equity-method investment losses, mainly because of deteriorating results at overseas affiliates.
  3. FY2026-H1WorsenedAnnual report

    「In non-operating income and expenses, royalty income, mainly from licenses for the development and sale of fingolimod, "FTY720," declined, while sales at a Chinese associate also fell. Ordinary profit was ¥6,455 million, down 7.4% year on year.」

    The previous fiscal year cited improved earnings at associates, while the current interim period identified lower sales at a Chinese associate as a factor weighing on ordinary profit.
  4. FY2025MitigatedAnnual report

    「In addition, improved earnings at associates in Thailand, China and Japan led to the recognition of an equity-method investment gain of ¥240 million, compared with an investment loss of ¥549 million in the previous consolidated fiscal year.」

    Improved earnings at associates in Thailand, China and Japan turned equity-method investment gains and losses from a ¥549 million loss in the previous fiscal year to a ¥240 million gain.
  5. FY2025-H1MitigatedAnnual report

    「In addition, improved earnings at the Thai associate and higher sales of diluted beverages at domestic associates led to the recognition of an equity-method investment gain of ¥111 million, compared with an investment loss of ¥121 million in the same period of the previous year.」

    Improved earnings at the Thai associate and other factors improved equity-method investment gains and losses from a ¥121 million loss in the same period of the previous year to a ¥111 million gain.
  6. FY2024WorsenedAnnual report

    「In addition, equity-method investment gains and losses were affected throughout the fiscal year by deteriorating earnings at the Thai associate due to lower production and sales volumes caused by a sugarcane shortage.」

    At the Thai associate, lower production and sales volumes due to a sugarcane shortage and deteriorating earnings continued throughout the fiscal year, contributing to an equity-method investment loss of ¥549 million.
  7. FY2024-Q3MitigatedAnnual report

    「In non-operating income and expenses, DM Mitsui Sugar Co., Ltd. recorded ¥4,457 million in dividend income received from domestic investees and ¥971 million in royalty income under licenses for the development and sale of fingolimod, "FTY720." In addition, equity-method investment gains and losses benefited mainly from improved earnings at the Thai associate, resulting in ordinary profit of ¥7,369 million, up 704.5% year on year.」

    For the Thai associate, deteriorating earnings due to lower sales volumes and other factors had been reported through the previous quarter, while earnings improved in the current quarter.
  8. FY2024-Q2RestatedAnnual report

    「Although equity-method investment gains and losses were affected mainly by deteriorating earnings due to lower sales volumes at the Thai associate, ordinary profit was ¥6,187 million, up 336.9% year on year.」

    Deteriorating earnings due to lower sales volumes at the Thai associate continued to be cited as a factor affecting equity-method investment gains and losses.
  9. FY2024-Q1WorsenedAnnual report

    「Although equity-method investment gains and losses were affected by deteriorating earnings due to lower sales and production volumes at the Thai and Chinese associates, ordinary profit was ¥5,272 million, up 457.4% year on year, and net profit for the quarter attributable to owners of the parent was ¥5,549 million, up 677.1%.」

    At the Thai and Chinese associates, deteriorating earnings due to lower sales and production volumes put downward pressure on equity-method investment gains and losses.
  10. FY2023-Q3WorsenedAnnual report

    「In equity-method investment gains and losses, ordinary profit was ¥916 million, down 74.9% year on year, due to lower sales volumes at associates affected by strict movement restrictions accompanying the spread of COVID-19 in China, as well as deteriorating earnings at the Thai associate.」

    Sales volumes at the Chinese associates continued to decline due to strict movement restrictions, while earnings at the Thai associate also deteriorated, making equity-method investment gains and losses a factor behind the decline in ordinary profit.
  11. FY2023-Q2Lower sales at the Chinese associates, while the Thai business partially improvedAnnual report

    「In equity-method investment gains and losses, sales volumes at the associates declined due to strict movement restrictions accompanying the spread of COVID-19 in China, while the cost ratio at the Thai associate partially improved due to higher production volumes and other factors. Ordinary profit was ¥1,416 million, down 41.5% year on year.」

    Sales volumes at the Chinese associates declined due to strict movement restrictions, while the cost ratio at the Thai associate partially improved as production volumes increased.
  12. FY2023-Q1Sales volumes at the Chinese affiliate declined due to movement restrictions.Annual report

    「Equity in earnings of affiliates resulted in ordinary profit of ¥945 million, down 35.8% year on year, due partly to lower sales volumes at the Chinese affiliate as a result of movement restrictions associated with the spread of COVID-19.」

    At the Chinese associates, lower sales volumes due to movement restrictions were cited as a factor behind the decreases in equity-method investment gains and losses and ordinary profit.
  13. FY2022WorsenedAnnual report

    「In equity-method investment gains and losses, the businesses of the Chinese associates continued to expand, including the start of Spoon-brand refined sugar production in May, while the cost ratio at the Thai associate deteriorated due to higher raw material costs. Ordinary profit was ¥3,479 million, compared with ¥3,788 million in the previous consolidated fiscal year.」

    The Chinese associates expanded through the start of refined sugar production and other developments, while the Thai associate's cost ratio deteriorated due to higher raw material costs, contributing to the deterioration in equity-method investment gains and losses.
  14. FY2022-Q3WorsenedAnnual report

    「In equity-method investment gains and losses, the businesses of the Chinese associates continued to perform well, partly due to an improved cost ratio, while earnings in the Thai business deteriorated due to higher depreciation expenses for a new plant and other factors. Ordinary profit was ¥3,648 million, compared with ¥3,460 million in the same quarter of the previous year.」

    Earnings in the Thai business deteriorated due to higher depreciation expenses for a new plant and other factors. Meanwhile, the Chinese associates continued to perform well, partly due to an improved cost ratio.
  15. FY2022-Q2MitigatedAnnual report

    「In equity-method investment gains and losses, the businesses of the Chinese associates continued to perform well, while earnings in the Thai business also improved, resulting in ordinary profit of ¥2,420 million, compared with ¥1,727 million in the same quarter of the previous year.」

    The Chinese associates' businesses performed well and earnings in the Thai business improved, easing the previous deterioration in equity-method investment gains and losses.
  16. FY2021MitigatedAnnual report

    「An equity-method investment loss was recorded, mainly because the Thai associate's earnings deteriorated sharply due to a poor sugarcane harvest caused by drought.」

    Although deterioration in the Thai associate's earnings and equity-method investment losses continued, the investment loss narrowed from ¥931 million in the previous fiscal year to ¥494 million in the current fiscal year.
  17. FY2021-Q3Equity-method investment losses narrowed from the same period of the previous year, but recovery at the Thai associate was delayedAnnual report

    「Due to lower royalty income, redevelopment work at the former Nagata plant site in the real estate business, and delayed earnings recovery at the Thai associate due to a sugarcane shortage, the Group recorded lower revenue and lower profit year on year.」

    Earnings recovery at the Thai associate was delayed by a sugarcane shortage. Meanwhile, equity-method investment losses narrowed from ¥1,038 million in the cumulative period of the previous year to ¥490 million.
  18. FY2021-Q2MitigatedAnnual report

    「Although results improved from the same period of the previous year, the recognition of an equity-method investment loss, among other factors, resulted in ordinary income of ¥1,727 million, down 43.5% year on year, and net income attributable to owners of the parent of ¥440 million, down 73.8%.」

    An equity-method investment loss was recorded, although it was described as an improvement from the same period of the previous year.
  19. FY2021-Q1WorsenedAnnual report

    「Among consolidated subsidiaries, 生和糖業㈱ achieved higher revenue and profit as production increased due to favorable sugarcane growth. Meanwhile, in addition to poor performance at 北海道糖業㈱, SIS' 88 Pte Ltd posted lower revenue and profit due to the spread of COVID-19.」

    For equity-method investment gains and losses, including those of Thai affiliates, an equity-method investment loss of ¥288 million was recorded in the quarter. The loss increased from ¥87 million in the same period of the previous year.
  20. FY2020-Q3WorsenedAnnual report

    「Ordinary income was ¥4,800 million, down 41.1% year on year, due to weak performance at Thai affiliates amid sluggish overseas raw sugar prices and the deferral of recognition of part of the revenue because arbitration proceedings concerning royalty income from “FTY720” remain ongoing.」

    As weak performance at Thai affiliates continued, the cumulative equity-method investment loss increased to ¥1,038 million from ¥823 million in the same period of the previous year.
  21. FY2020-Q2WorsenedAnnual report

    「Ordinary income fell below the previous year due to amortization of goodwill from overseas investments made since the previous year and deteriorating performance at Thai affiliates caused by weak overseas raw sugar prices.」

    As deteriorating performance at Thai affiliates continued, the equity-method investment loss increased from ¥485 million in the same period of the previous year to ¥845 million.
  22. FY2020-Q1WorsenedAnnual report

    「Selling prices at Thai affiliates declined amid weak overseas raw sugar prices, while affiliates in Okinawa and Kagoshima were affected by lower yields due to poor weather. An equity-method investment loss of ¥87 million was recorded, resulting in ordinary income of ¥1,945 million, down 35.4% year on year.」

    Due to lower selling prices at Thai affiliates and lower yields at domestic affiliates, results deteriorated from equity-method investment income to an investment loss of ¥87 million.
  23. FY2019RestatedAnnual report

    「At Thai affiliates, selling prices declined amid weak overseas raw sugar prices. At affiliates in Okinawa and Kagoshima, equity-method investment losses were recognized, partly due to the impact of low sugar content in raw sugarcane caused by poor weather.」

    The recognition of equity-method investment losses due to lower selling prices at Thai affiliates and low sugar content in Okinawa and Kagoshima was also confirmed in the full-year results.
  24. FY2019-Q3WorsenedAnnual report

    「In non-operating income and expenses, royalty income of ¥6,053 million was recorded. However, performance at Thai affiliates deteriorated amid weak overseas raw sugar prices, while affiliates in Okinawa and Kagoshima were affected by poor weather, resulting in ordinary income of ¥8,146 million, down 28.3% year on year, and net income attributable to owners of the parent of ¥5,031 million, down 30.3%.」

    Deteriorating performance at Thai affiliates due to weak raw sugar prices continued, and poor weather in Okinawa and Kagoshima also contributed to the decline in ordinary income and other results.
  25. FY2019-Q2WorsenedAnnual report

    「In non-operating income and expenses, royalty income of ¥3,934 million was recorded. However, an equity-method investment loss of ¥485 million was recognized, mainly due to the Thai business, resulting in ordinary income of ¥4,971 million, down 38.6% year on year.」

    Due mainly to the Thai business, results deteriorated from equity-method investment income to an investment loss of ¥485 million.
  26. FY2019-Q1Significant decline in equity-method investment incomeAnnual report

    「In non-operating income and expenses, royalty income of ¥1,808 million was recorded. However, equity-method investment income was limited to ¥41 million due to poor performance in the Thai business caused by weak raw sugar prices and lower production at domestic affiliates due to weather conditions, resulting in ordinary income of ¥3,012 million, down 32.3% year on year, and net income attributable to owners of the parent of ¥1,929 million, down 33.9%.」

    Equity-method investment income was limited to ¥41 million due to poor performance in the Thai business and lower production at domestic affiliates.
  27. FY2018-Q3Continuation of equity-method investment lossesAnnual report

    「In non-operating income and expenses, an equity-method investment loss was recorded at a Thai affiliate, mainly due to deteriorating earnings caused by weak raw sugar prices. However, royalty income of ¥5,744 million was recorded, resulting in ordinary income of ¥11,362 million, up 23.6% year on year.」

    An equity-method investment loss was recorded at a Thai affiliate, mainly due to deteriorating earnings caused by weak raw sugar prices.
  28. FY2018-Q1Recovery in equity-method investment incomeAnnual report

    「In non-operating income and expenses, royalty income of ¥1,647 million and equity-method investment income of ¥592 million were recorded, resulting in ordinary income of ¥4,450 million, up 33.9% year on year, and net income attributable to owners of the parent of ¥2,917 million, up 40.7%.」

    Against the deterioration in Thai affiliate performance and decline in equity-method investment income reported in the previous fiscal year, equity-method investment income of ¥592 million was recorded in the first quarter.
  29. FY2017SoftenedAnnual report

    「In non-operating income and expenses, royalty income of ¥7,505 million was recorded. However, equity-method investment income declined, mainly due to deteriorating performance at Thai affiliates affected by reduced sugarcane production caused by drought, resulting in ordinary income of ¥12,494 million, down 2.4% year on year.」

    Although equity-method investment income declined due to deteriorating performance at Thai affiliates, the full-year results reflected investment income rather than the investment loss recognized in the third quarter.
  30. FY2017-Q3Recognition of equity-method investment losses due to deteriorating performance at Thai affiliatesAnnual report

    「In non-operating income and expenses, royalty income of ¥5,401 million was recorded. However, equity-method investment losses were recognized, mainly due to deteriorating performance at Thai affiliates caused by drought and other factors. Ordinary income was ¥9,196 million, down 11.4% year on year, and net income attributable to owners of the parent was ¥5,677 million, down 6.1%.」

    As deteriorating performance at Thai affiliates continued due to drought and other factors, equity-method investment income changed to investment losses.
  31. FY2017-Q2First statedAnnual report

    「In non-operating income and expenses, royalty income of ¥3,560 million was recorded. However, equity-method investment income fell below the same period of the previous year, mainly due to deteriorating performance at Thai affiliates, resulting in ordinary income of ¥5,800 million, down 7.3% year on year.」

    The results for the quarter show that equity-method investment income fell below the same period of the previous year, mainly due to deteriorating performance at Thai affiliates.
Moved together

"Contingent burden arising from guarantee obligations to non-consolidated companies" moved the same way as this thread, in the same document, in 13 of its 31 moves.

1365443★123456
  1. ★This thread
  2. 1Contingent burden arising from guarantee obligations to non-consolidated companies13×
  3. 2Decline in sugar sales volumes due to unsettled summer weather and lower sales to mass retailers6×
  4. 3Fluctuations in Raw Sugar Prices and Product Selling Prices5×
  5. 4Making the food science business the Group's second core business after sugar4×
  6. 5Asian Expansion Centered on China and Thailand4×
  7. 6Rebuilding the business foundation and growth areas, with 2022 as the target year3×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Mitsui DM Sugar's next results are scheduled for 2026-10-30. Read the earnings preview It last moved in the Revision of earnings forecasts of 2026-05-15: "Worsened".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.